These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20832356)

  • 1. Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.
    Stewart P; Cachafeiro A; Napravnik S; Eron JJ; Frank I; van der Horst C; Bosch RJ; Bettendorf D; Bohlin P; Fiscus SA
    J Clin Virol; 2010 Nov; 49(3):198-204. PubMed ID: 20832356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay.
    Jennings C; Fiscus SA; Crowe SM; Danilovic AD; Morack RJ; Scianna S; Cachafeiro A; Brambilla DJ; Schupbach J; Stevens W; Respess R; Varnier OE; Corrigan GE; Gronowitz JS; Ussery MA; Bremer JW
    J Clin Microbiol; 2005 Dec; 43(12):5950-6. PubMed ID: 16333081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.
    Stevens G; Rekhviashvili N; Scott LE; Gonin R; Stevens W
    J Clin Microbiol; 2005 Feb; 43(2):857-61. PubMed ID: 15695692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the ExaVir Load version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load.
    Labbett W; Garcia-Diaz A; Fox Z; Clewley GS; Fernandez T; Johnson M; Geretti AM
    J Clin Microbiol; 2009 Oct; 47(10):3266-70. PubMed ID: 19656978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings.
    Iqbal HS; Balakrishnan P; Cecelia AJ; Solomon S; Kumarasamy N; Madhavan V; Murugavel KG; Ganesh AK; Solomon SS; Mayer KH; Crowe SM
    J Med Microbiol; 2007 Dec; 56(Pt 12):1611-1614. PubMed ID: 18033828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected Patients.
    Borrego P; Gonçalves MF; Gomes P; Araújo L; Moranguinho I; Figueiredo IB; Barahona I; Rocha J; Mendonça C; Cruz MC; Barreto J; Taveira N
    J Clin Microbiol; 2017 Aug; 55(8):2367-2379. PubMed ID: 28515216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study.
    Mine M; Bedi K; Maruta T; Madziva D; Tau M; Zana T; Gaolathe T; Moyo S; Seipone K; Ndwapi N; Essex M; Marlink R
    J Virol Methods; 2009 Jul; 159(1):93-7. PubMed ID: 19442851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the low-cost Cavidi ExaVir Load assay for monitoring HIV viral load in pediatric and adult patients.
    Greengrass V; Lohman B; Morris L; Plate M; Steele PM; Walson JL; Crowe SM
    J Acquir Immune Defic Syndr; 2009 Nov; 52(3):387-90. PubMed ID: 19617845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.
    Greengrass VL; Plate MM; Steele PM; Denholm JT; Cherry CL; Morris LM; Hearps A; Crowe SM
    J Clin Microbiol; 2009 Sep; 47(9):3011-3. PubMed ID: 19605583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of a reverse transcriptase based assay for HIV-1 viral load quantitation in resource limited settings.
    Kokkayil P; Kurapati S; Negi N; Vajpayee M
    J Virol Methods; 2014 Jul; 203():1-4. PubMed ID: 24671025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda.
    Spacek LA; Lutwama F; Shihab HM; Summerton J; Kamya MR; Ronald A; Laeyendecker O; Quinn TC; Mayanja-Kizza H
    Int J STD AIDS; 2011 Jun; 22(6):310-4. PubMed ID: 21680665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings.
    Respess RA; Cachafeiro A; Withum D; Fiscus SA; Newman D; Branson B; Varnier OE; Lewis K; Dondero TJ
    J Clin Microbiol; 2005 Jan; 43(1):506-8. PubMed ID: 15635029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The performance of reverse transcriptase assay for the estimation of the plasma viral load in HIV-1 and HIV-2 infections.
    Padaki PA; Sachithanandham J; Isaac R; Ramalingam VV; Abraham OC; Pulimood SA; Kannangai R
    Infect Dis (Lond); 2016; 48(6):467-71. PubMed ID: 26654354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings.
    Steegen K; Luchters S; De Cabooter N; Reynaerts J; Mandaliya K; Plum J; Jaoko W; Verhofstede C; Temmerman M
    J Virol Methods; 2007 Dec; 146(1-2):178-87. PubMed ID: 17686534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA.
    Schüpbach J; Böni J; Flepp M; Tomasik Z; Joller H; Opravil M
    J Med Virol; 2001 Oct; 65(2):225-32. PubMed ID: 11536227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The measurement of HIV-1 viral load in resource-limited settings: how and where?
    Rouet F; Rouzioux C
    Clin Lab; 2007; 53(3-4):135-48. PubMed ID: 17447649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.
    Emery S; Bodrug S; Richardson BA; Giachetti C; Bott MA; Panteleeff D; Jagodzinski LL; Michael NL; Nduati R; Bwayo J; Kreiss JK; Overbaugh J
    J Clin Microbiol; 2000 Jul; 38(7):2688-95. PubMed ID: 10878065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 viral load measurement in venous blood and fingerprick blood using Abbott RealTime HIV-1 DBS assay.
    Tang N; Pahalawatta V; Frank A; Bagley Z; Viana R; Lampinen J; Leckie G; Huang S; Abravaya K; Wallis CL
    J Clin Virol; 2017 Jul; 92():56-61. PubMed ID: 28531553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring.
    Greengrass VL; Turnbull SP; Hocking J; Dunne AL; Tachedjian G; Corrigan GE; Crowe SM
    Curr HIV Res; 2005 Apr; 3(2):183-90. PubMed ID: 15853722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of the Abbott HIV-1 RealTime™ assay with the Standard Roche COBAS® Amplicor™ HIV-1 Monitor® Test, v1.5 for determining HIV-1 RNA levels in plasma specimens from Pune, India.
    Khopkar P; Mallav V; Chidrawar S; Kulkarni S
    J Virol Methods; 2013 Jul; 191(1):82-7. PubMed ID: 23588214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.